Endobronchial ultrasound and lymphoproliferative disorders: A retrospective study

Seher Iqbal, Zachary S. Depew, Paul J. Kurtin, Anne-Marie Gisele Sykes, Geoffrey B. Johnson, Eric Edell, Thomas Matthew Habermann, Fabien Maldonado

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been shown to have excellent diagnostic performance for mediastinal staging of lung cancer. The utility of EBUS-TBNA for the diagnosis of lymphoproliferative disorders involving the mediastinum or hila, or both, is unclear. Methods: A retrospective analysis was completed of all patients diagnosed with a lymphoproliferative disorder involving the mediastinum or hila, or both, who underwent an EBUS-TBNA within 3 months of the diagnosis. Results: Sixty-five patients with mediastinal or hilar lymph node, or both, involvement of their lymphoproliferative disorder underwent EBUS-TBNA within 3 months of their diagnosis. The initial EBUS-TBNA was nondiagnostic in 34 (52%), 11 were subsequently diagnosed by mediastinoscopy, and the remaining 23 were diagnosed by biopsy of a distant site, with involvement of the mediastinum or hilum assumed from preestablished radiographic criteria. A EBUS-TBNA specimen in 31 patients (48%) was interpreted as consistent with or suspicious for a lymphoproliferative disorder. The overall sensitivity of EBUS-TBNA for establishing a definitive diagnosis was 25 of 65 (38%). The sensitivity was lower for new patients, at 7 of 32 (22%), and better for patients with recurrence, at 18 of 33 (55%). Conclusions: Contrary to previous studies, our findings suggest that EBUS-TBNA does not provide sufficient diagnostic material for accurate lymphoproliferative disorder subtyping in a significant number of patients and performs especially poorly when evaluating new patients. Mediastinoscopy should still be considered as the initial diagnostic procedure of choice when the clinical suspicion for a lymphoproliferative disorder is high, unless the patient is being evaluated for a recurrence of prior disorder.

Original languageEnglish (US)
Pages (from-to)1830-1834
Number of pages5
JournalAnnals of Thoracic Surgery
Volume94
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Lymphoproliferative Disorders
Needles
Retrospective Studies
Mediastinum
Mediastinoscopy
Recurrence
Lung Neoplasms
Lymph Nodes
Biopsy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Endobronchial ultrasound and lymphoproliferative disorders : A retrospective study. / Iqbal, Seher; Depew, Zachary S.; Kurtin, Paul J.; Sykes, Anne-Marie Gisele; Johnson, Geoffrey B.; Edell, Eric; Habermann, Thomas Matthew; Maldonado, Fabien.

In: Annals of Thoracic Surgery, Vol. 94, No. 6, 12.2012, p. 1830-1834.

Research output: Contribution to journalArticle

Iqbal, Seher ; Depew, Zachary S. ; Kurtin, Paul J. ; Sykes, Anne-Marie Gisele ; Johnson, Geoffrey B. ; Edell, Eric ; Habermann, Thomas Matthew ; Maldonado, Fabien. / Endobronchial ultrasound and lymphoproliferative disorders : A retrospective study. In: Annals of Thoracic Surgery. 2012 ; Vol. 94, No. 6. pp. 1830-1834.
@article{740bdb8e7347427385d96deb12da076a,
title = "Endobronchial ultrasound and lymphoproliferative disorders: A retrospective study",
abstract = "Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been shown to have excellent diagnostic performance for mediastinal staging of lung cancer. The utility of EBUS-TBNA for the diagnosis of lymphoproliferative disorders involving the mediastinum or hila, or both, is unclear. Methods: A retrospective analysis was completed of all patients diagnosed with a lymphoproliferative disorder involving the mediastinum or hila, or both, who underwent an EBUS-TBNA within 3 months of the diagnosis. Results: Sixty-five patients with mediastinal or hilar lymph node, or both, involvement of their lymphoproliferative disorder underwent EBUS-TBNA within 3 months of their diagnosis. The initial EBUS-TBNA was nondiagnostic in 34 (52{\%}), 11 were subsequently diagnosed by mediastinoscopy, and the remaining 23 were diagnosed by biopsy of a distant site, with involvement of the mediastinum or hilum assumed from preestablished radiographic criteria. A EBUS-TBNA specimen in 31 patients (48{\%}) was interpreted as consistent with or suspicious for a lymphoproliferative disorder. The overall sensitivity of EBUS-TBNA for establishing a definitive diagnosis was 25 of 65 (38{\%}). The sensitivity was lower for new patients, at 7 of 32 (22{\%}), and better for patients with recurrence, at 18 of 33 (55{\%}). Conclusions: Contrary to previous studies, our findings suggest that EBUS-TBNA does not provide sufficient diagnostic material for accurate lymphoproliferative disorder subtyping in a significant number of patients and performs especially poorly when evaluating new patients. Mediastinoscopy should still be considered as the initial diagnostic procedure of choice when the clinical suspicion for a lymphoproliferative disorder is high, unless the patient is being evaluated for a recurrence of prior disorder.",
author = "Seher Iqbal and Depew, {Zachary S.} and Kurtin, {Paul J.} and Sykes, {Anne-Marie Gisele} and Johnson, {Geoffrey B.} and Eric Edell and Habermann, {Thomas Matthew} and Fabien Maldonado",
year = "2012",
month = "12",
doi = "10.1016/j.athoracsur.2012.08.051",
language = "English (US)",
volume = "94",
pages = "1830--1834",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Endobronchial ultrasound and lymphoproliferative disorders

T2 - A retrospective study

AU - Iqbal, Seher

AU - Depew, Zachary S.

AU - Kurtin, Paul J.

AU - Sykes, Anne-Marie Gisele

AU - Johnson, Geoffrey B.

AU - Edell, Eric

AU - Habermann, Thomas Matthew

AU - Maldonado, Fabien

PY - 2012/12

Y1 - 2012/12

N2 - Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been shown to have excellent diagnostic performance for mediastinal staging of lung cancer. The utility of EBUS-TBNA for the diagnosis of lymphoproliferative disorders involving the mediastinum or hila, or both, is unclear. Methods: A retrospective analysis was completed of all patients diagnosed with a lymphoproliferative disorder involving the mediastinum or hila, or both, who underwent an EBUS-TBNA within 3 months of the diagnosis. Results: Sixty-five patients with mediastinal or hilar lymph node, or both, involvement of their lymphoproliferative disorder underwent EBUS-TBNA within 3 months of their diagnosis. The initial EBUS-TBNA was nondiagnostic in 34 (52%), 11 were subsequently diagnosed by mediastinoscopy, and the remaining 23 were diagnosed by biopsy of a distant site, with involvement of the mediastinum or hilum assumed from preestablished radiographic criteria. A EBUS-TBNA specimen in 31 patients (48%) was interpreted as consistent with or suspicious for a lymphoproliferative disorder. The overall sensitivity of EBUS-TBNA for establishing a definitive diagnosis was 25 of 65 (38%). The sensitivity was lower for new patients, at 7 of 32 (22%), and better for patients with recurrence, at 18 of 33 (55%). Conclusions: Contrary to previous studies, our findings suggest that EBUS-TBNA does not provide sufficient diagnostic material for accurate lymphoproliferative disorder subtyping in a significant number of patients and performs especially poorly when evaluating new patients. Mediastinoscopy should still be considered as the initial diagnostic procedure of choice when the clinical suspicion for a lymphoproliferative disorder is high, unless the patient is being evaluated for a recurrence of prior disorder.

AB - Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been shown to have excellent diagnostic performance for mediastinal staging of lung cancer. The utility of EBUS-TBNA for the diagnosis of lymphoproliferative disorders involving the mediastinum or hila, or both, is unclear. Methods: A retrospective analysis was completed of all patients diagnosed with a lymphoproliferative disorder involving the mediastinum or hila, or both, who underwent an EBUS-TBNA within 3 months of the diagnosis. Results: Sixty-five patients with mediastinal or hilar lymph node, or both, involvement of their lymphoproliferative disorder underwent EBUS-TBNA within 3 months of their diagnosis. The initial EBUS-TBNA was nondiagnostic in 34 (52%), 11 were subsequently diagnosed by mediastinoscopy, and the remaining 23 were diagnosed by biopsy of a distant site, with involvement of the mediastinum or hilum assumed from preestablished radiographic criteria. A EBUS-TBNA specimen in 31 patients (48%) was interpreted as consistent with or suspicious for a lymphoproliferative disorder. The overall sensitivity of EBUS-TBNA for establishing a definitive diagnosis was 25 of 65 (38%). The sensitivity was lower for new patients, at 7 of 32 (22%), and better for patients with recurrence, at 18 of 33 (55%). Conclusions: Contrary to previous studies, our findings suggest that EBUS-TBNA does not provide sufficient diagnostic material for accurate lymphoproliferative disorder subtyping in a significant number of patients and performs especially poorly when evaluating new patients. Mediastinoscopy should still be considered as the initial diagnostic procedure of choice when the clinical suspicion for a lymphoproliferative disorder is high, unless the patient is being evaluated for a recurrence of prior disorder.

UR - http://www.scopus.com/inward/record.url?scp=84870011178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870011178&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2012.08.051

DO - 10.1016/j.athoracsur.2012.08.051

M3 - Article

C2 - 23084417

AN - SCOPUS:84870011178

VL - 94

SP - 1830

EP - 1834

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6

ER -